Activation, binding, and processing of complement component 3 (C3) by Blastomyces dermatitidis

Infection and Immunity

Volumn 65, Issue 5, 1997, Pages 1849-1855

  Zhang, Mason X ^a   Klein, Bruce ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; HYDROXYLAMINE;

ARTICLE; BLASTOMYCES DERMATITIDIS; CELL WALL; COMPLEMENT ACTIVATION; COMPLEMENT FIXATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; OPSONIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN IMMOBILIZATION; PROTEIN PROCESSING; YEAST;

EID: 0030901449     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.5.1849-1855.1997     Document Type: Article

References (29)

1. Bacon, J. S. D., V. C. Farmer, D. Jones, and I. F. Taylor. 1969. The glucan components of the cell wall of Baker's yeast (Saccharomyces cerevisiae) considered in relation to its ultrastructure. Biochem. J. 114:557-567.
2. DiCarlo, F. J., and J. V. Fiore. 1958. On the composition of zymosan. Science 127:756-757.
3. Drutz, D. J., and C. L. Frey. 1985. Intracellular and extracellular defenses of human phagocytes against Blastomyces dermatitidis conidia and yeasts. J. Lab. Clin. Med. 105:737-750.
4. Fine, D. P., S. R. Marney, Jr., D. G. Colley, J. S. Sergent, and R. M. Des Prez. 1972. C3 shunt activation in human serum chelated with EGTA. J. Immunol. 109:807-809.
5. Hogan, L. H., and B. S. Klein. 1994. Altered expression of surface α-1,3-glucan in genetically related strains of Blastomyces dermatitidis that differ in virulence. Infect. Immun. 62:3543-3546.
6. Ikeda, K., T. Sannoh, N. Kawasaki, T. Kawasaki, and I. Yamashina. 1987. Serum lectin with known structure activates complement through the classical pathway. J. Biol. Chem. 262:7451-7454.
7. Kanetsuna, F., and L. M. Carbonell. 1971. Cell wall composition of the yeastlike and mycelial forms of Blastomyces dermatitidis. J. Bacteriol. 106:946-948.
8. Keller, R. G., G. S. T. Pfrommer, and T. R. Kozel. 1994. Occurrences, specificities, and functions of ubiquitous antibodies in human serum that are reactive with the Cryptococcus neoformans cell wall. Infect. Immun. 62:215-220.
9. Klein, B. S. 1992. Immunology of blastomycosis, p. 133-163. In Y. Al-Doory and A. F. DiSalvo (ed.), Blastomycosis. Plenum Medical Book Company, New York, N.Y.
10. Klein, B. S., and J. M. Jones. 1990. Isolation, purification, and radiolabeling of a novel 120-kD surface protein on Blastomyces dermatitidis yeasts to detect antibody in infected patients. J. Clin. Invest. 85:152-161.
11. Klimpel, K. R., and W. E. Goldman. 1988. Cell walls from avirulent variants of Histoplasma capsulatum lack α-(1,3)-glucan. Infect. Immun. 56:2997-3000.
12. Kohler, P. F., and H. J. Muller-Eberhard. 1967. Immunochemical quantitation of the third, fourth and fifth components of human complement: concentrations in the serum of healthy adults. J. Immunol. 99:1211-1216.
13. 12a.Kozel, T. Personal communication.
14. Kozel, T., M. Wilson, and J. Murphy. 1991. Early events in initiation of alternative complement pathway activation by the capsule of Cryptococcus neoformans. Infect. Immun. 59:3101-3110.
15. Kozel, T. R. 1996. Activation of the complement system by pathogenic fungi. Clin. Microbiol. Rev. 9:34-46.
16. Kozel, T. R., R. R. Brown, and G. S. T. Pfrommer. 1987. Activation and binding of C3 by Candida albicans. Infect, Immun. 55:1890-1894.
17. Kozel, T. R., L. C. Weinhold, and D. M. Lupan. 1996. Distinct characteristics of initiation of the classical and alternative complement pathways by Candida albicans. Infect. Immun. 64:3360-3368.
18. Kozel, T. R., M. A. Wilson, G. S. T. Pfrommer, and A. M. Schlageter. 1989. Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins. Infect. Immun. 57:1922-1927.
19. Law, S. K., and R. P. Levine. 1977. Interaction between the third complement protein and cell surface macromolecules. Proc. Natl. Acad. Sci. USA 74:2701-2705.
20. Law, S. K., N. A. Lichtenberg, and R. P. Levine. 1979. Evidence for an ester linkage between the labile binding site of C3b and receptive surfaces. J. Immunol. 123:1388-1394.
21. Lu, J., S. Thiel, H. Wiedemann, R. Timpl, and K. B. M. Reid. 1990. Binding of the pentamer/hexamer forms of mannan-binding protein to zymosan activates the proenzyme C1r2C1s2 complex, of the classical pathway of complement, without involvement of C1q. J. Immunol. 144:2287-2294.
22. Matsushita, M., and T. Fujita. 1992. Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease. J. Exp. Med. 176:1497-1502.
23. Newinan, S. L., and L. K. Mikus. 1985. Deposition of C3b and iC3b onto particulate activators of the human complement system. J. Exp. Med. 161:1414-1431.
24. Newman, S. L., S. Chaturvedi, and B. S. Klein. 1994. WI-1 antigen on Blastomyces dermatitidis yeasts mediates binding to human macrophage CR3 (CD11b/CD18) and CD14. J. Immunol. 154:753-761.
25. 0 analog L-733,560. Antimicrob. Agents Chemother. 38:2258-2265.
26. Pfrommer, G. S. T., S. M. Dickens, M. A. Wilson, B. J. Young, and T. R. Kozel. 1993. Accelerated decay of C3b to iC3b when C3b is bound to the Cryptococcus neoformans capsule. Infect. Immun. 61:4360-4366.
27. Sugar, A. M. 1992. Taxonomy and biology of Blastomyces dermatitidis, p. 9-29. In Y. Al-Doory and A. F. DiSalvo (ed.), Blastomycosis. Plenum Medical Book Company, New York, N.Y.
28. Wilson, M. A., and T. R. Kozel. 1992. Contribution of antibody in normal human serum to early deposition of C3 onto encapsulated and nonencapsulated Cryptococcus neoformans. Infect. Immun. 60:754-761.
29. Worsham, P. L., and W. E. Goldman. 1988. Quantitative plating of Histoplasma capsulatum without addition of conditioned medium or siderophores. J. Med. Vet. Mycol. 26:137-143.